cadila healthcare ltd (CDH:Natl India)
Transactions by CADILA HEALTHCARE LTD (CDH) in the last 6 months
Cadila Healthcare Limited (BSE:532321) announced a private placement for gross proceeds of INR 100,000,000,000 on April 8, 2015. The company will issue common shares, convertible bonds or convertible debenture and/or depository receipts. The board of directors approved the transaction. The transaction is subject to shareholders’ approval. The company will issue securities through qualified institutional placement.
Cadila Healthcare Limited (BSE:532321) acquired remaining 50% stake in Zydus BSV Pharma Pvt. Ltd. from Bharat Serums and Vaccines Limited on March 26, 2015. Post-acquisition, Zydus BSV has become a wholly-owned subsidiary of Cadila Healthcare.
|Cipla Ltd/India||631.65 INR||+3.20|
|Glenmark Pharmaceuticals Ltd||861.00 INR||-7.95|
|Piramal Enterprises Ltd||980.60 INR||+45.25|
|Torrent Pharmaceuticals Ltd||1,191 INR||+21.10|
|Wockhardt Ltd||1,244 INR||-84.45|
|View Industry Companies|